GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bora Pharmaceuticals Co Ltd (TPE:6472) » Definitions » 12-1 Month Momentum %

Bora Pharmaceuticals Co (TPE:6472) 12-1 Month Momentum % : 24.12% (As of Dec. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bora Pharmaceuticals Co 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-15), Bora Pharmaceuticals Co's 12-1 Month Momentum % is 24.12%.

The industry rank for Bora Pharmaceuticals Co's 12-1 Month Momentum % or its related term are showing as below:

TPE:6472's 12-1 Month Momentum % is ranked better than
75.26% of 1063 companies
in the Drug Manufacturers industry
Industry Median: -4.2 vs TPE:6472: 24.12

Competitive Comparison of Bora Pharmaceuticals Co's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Bora Pharmaceuticals Co's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bora Pharmaceuticals Co's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bora Pharmaceuticals Co's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Bora Pharmaceuticals Co's 12-1 Month Momentum % falls into.



Bora Pharmaceuticals Co  (TPE:6472) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bora Pharmaceuticals Co  (TPE:6472) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Bora Pharmaceuticals Co 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Bora Pharmaceuticals Co's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bora Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 2, Aly. 36, Lane 26, Ruiguang Road, 6th Floor, Neihu District, Taipei, TWN, 114
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Commercial sales segment, Contract Development & Manufacturing Organization segment, and Other segment. The majority of revenue is derived from the Commercial sales segment. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.

Bora Pharmaceuticals Co Headlines

No Headlines